Drug recall · May 11, 2022
Lidocaine Hydrochloride Oral Topical Solution recall
Why: Failed viscosity specification - product was below specificcation
Class III: unlikely to cause harm, but breaks the rules (for example a labeling error).
The recall
- Product
Lidocaine Hydrochloride Oral Topical Solution, USP (Viscous) 2%, 100 mL per bottle, Rx only, Manufactured by Hi-Tech Pharmacal Co., Inc. Amityville, NY 11701, NDC 50383-775-04
- Lots / codes
Lot #: 370978, Exp 9/30/2022
- Quantity
- 66,744 bottles
- Company
- Akorn, Inc., Lake Forest, IL
- Distribution
- Nationwide USA and Puerto Rico
- Initiated
- April 15, 2022 · Voluntary: Firm initiated
- Classified
- May 5, 2022
- Reported
- May 11, 2022
- Ended
- September 28, 2023
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Lidocaine
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.